A recent research has shown that maple syrup could reduce the risk of getting Alzheimer’s disease. The study showed that a compound found in maple syrup actually reduced the activation of a particular type of protein found in the brain of Alzheimer’s patients.
Multiple Studies Show Similar Results
Several studies in the US and Canada have all shown that maple syrup could have the potential to inhibit the onset and degeneration of Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). ALS is a neurodegenerative disorder affecting the motor neurons. Researchers have found that pure maple syrup that comes from Canada is one hundred percent natural and contains the therapeutic nutrients and compounds that may be beneficial against Alzheimer’s and ALS.
Alzheimer’s, and other brain-related diseases, occur when the cellular proteins cluster together and fail to integrate properly, leaving the form of coating that is part of the pathogenesis of the diseases. The studies showed that maple syrup extract reduced the aggregation of the two peptides which are the pathological markers of Alzheimer’s disease, B-amyloid and Tau.
Fighting ALS with Syrup
The mutated TDP-43 gene, which is involved in the onset of ALS by causing the TDP-43 protein to aggregate in neuronal cells, when subjected to the compounds in the syrup, showed a decrease in the damage to the neuronal proteins. However, this has yet to be fully researched, as little study has yet been done on the effectiveness of maple syrup in ALS. So far it has only undergone testing for the protective activity in the TDP-43 gene in worms.
At the American Chemical Society‘s annual meeting, the beneficial effects of pure maple syrup were discussed and the results of 24 different studies on the use of maple syrup in brain health were shared by leading international researchers. They also showed that an extract of maple syrup had prolonged the lifespan of an Alzheimer’s roundworm model, giving hope that it may be utilized in the same way in human sufferers. However, further animal studies would need to be done before moving on to human trials.
Investment in Research
The Federation of Quebec Maple Syrup Producers has made a commitment to invest further in the study of the effects of maple syrup compounds on Alzheimer’s and ALS patients. The research was started in 2005 to explore the potential benefits of maple syrup in health matters. It is already well known that maple syrup has anti-inflammatory benefits in its more-than 100 bioactive compounds. “Brain health is the latest topic of exploration and we look forward to learning more about the potential benefits that maple syrup might have in this area,” said Serge Beaulieu, president of the Federation of Quebec Maple Syrup Producers.
Studies on the MIND Diet, which also includes other beneficial foods such as berries, nuts, fish, vegetables and olive oil have already shown that healthy eating can reduce the risk of getting Alzheimer’s disease by as much as 50%. Maple syrup may have the potential to reduce that even further.
Related articles published in Maple Syrup’s Health Benefits :
- Maple syrup triggers hope for patients with Alzheimer’s disease
- Homemade maple syrup made easy
- Maple syrup classified as an unmatched nutrient powerhouse
- Six Reasons Why Vegans Should Adopt Maple Syrup
Image : Shutterstock